Evidence map›Paper›PMID 21248736›Full record

ArticleEuropean journal of human genetics : EJHG2011

Beckwith-Wiedemann syndrome and uniparental disomy 11p: fine mapping of the recombination breakpoints and evaluation of several techniques.

Valeria Romanelli, Heloisa N M Meneses, Luis Fernández, Victor Martínez-Glez, Ricardo Gracia-Bouthelier, Mario F Fraga, Encarna Guillén, Julián Nevado, Esther Gean, Loreto Martorell and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. (Epi)genotype-phenotype correlations in Beckwith-Wiedemann syndrome.European journal of human genetics : EJHG · 2016
    Article
  15. Article
  16. Cystic fibrosis and beckwith-wiedemann syndrome: a case report.Journal of clinical medicine research · 2015
    Article
  17. Neonatal tumours.Pediatric surgery international · 2013
    Review
  18. Article
  19. A genomic view of mosaicism and human disease.Nature reviews. Genetics · 2013
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 2 countries.

Valeria RomanelliINGEMM, Instituto de Genética Médica y Molecular, IDIPaz, Hospital Universitario La Paz, Universidad Autónoma de Madrid, Madrid, Spain.
Heloisa N M Meneses
Luis Fernández
Victor Martínez-Glez
Ricardo Gracia-Bouthelier
Mario F Fraga
Encarna Guillén
Julián Nevado
Esther Gean
Loreto Martorell
Victoria Esteban Marfil
Sixto García-Miñaur
Pablo Lapunzina
Hospital Universitario La Paz · ESCentro de Investigación Biomédica en Red · ESHospital Sant Joan de Déu Barcelona · ESCentre for Biomedical Network Research on Rare Diseases · ESCentro Nacional de Biotecnología · ESComplejo Hospitalario de Jaén · ESHospital Universitario Virgen de la Arrixaca · ESUniversidad Autónoma de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Beckwith-Wiedemann syndrome (BWS) is a phenotypically and genotypically heterogeneous overgrowth syndrome characterized by somatic overgrowth, macroglossia and abdominal wall defects. Other usual findings are hemihyperplasia, embryonal tumours, adrenocortical cytomegaly, ear anomalies, visceromegaly, renal abnormalities, neonatal hypoglycaemia, cleft palate, polydactyly and a positive family history. BWS is a complex, multigenic disorder associated, in up to 90% of patients, with alteration in the expression or function of one or more genes in the 11p15.5 imprinted gene cluster. There are several molecular anomalies associated with BWS and the large proportion of cases, about 85%, is sporadic and karyotypically normal. One of the major categories of BWS molecular alteration (10-20% of cases) is represented by mosaic paternal uniparental disomy (pUPD), namely patients with two paternally derived copies of chromosome 11p15 and no maternal contribution for that. In these patients, in addition to the effects of IGF2 overexpression, a decreased level of the maternally expressed gene CDKN1C may contribute to the BWS phenotype. In this paper, we reviewed a series of nine patients with BWS because of pUPD using several methods with the aim to evaluate the percentage of mosaicism, the methylation status at both loci, the extension of the pUPD at the short arm and the breakpoints of recombination. Fine mapping of mitotic recombination breakpoints by single-nucleotide polymorphism-array in individuals with UPD and fine estimation of epigenetic defects will provide a basis for understanding the aetiology of BWS, allowing more accurate prognostic predictions and facilitating management and surveillance of individuals with this disorder.

Indexed as

Beckwith-Wiedemann SyndromeChromosome BreakpointsChromosome MappingChromosomes, Human, Pair 11DNA MethylationEpigenomicsGenomic ImprintingHumansInsulin-Like Growth Factor IIMicrosatellite RepeatsMosaicismOligonucleotide Array Sequence AnalysisPhenotypeSequence Analysis, DNAUniparental DisomyIGF2 protein, humanInsulin-Like Growth Factor II

Identifiers

PMID21248736
PMCPMC3060332
OpenAlexW2007539432

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.